Skip to main content

New Products: Illumina's Accelerator Program

Premium

Illumina has launched its Accelerator Program, a business accelerator that will focus on speeding up the time to market and lowering barriers to entry for individuals and start-ups that are developing next-generation sequencing applications.

Illumina will invite participants to a six-month program, where it will provide technology and business guidance as well as $100,000 in support, including access to sequencing systems and reagents and laboratory space at facilities in San Francisco. Initial investors include Yuri Milner and Silicon Valley Bank.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.